Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Earnings per Share (CEPS)

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   CEPS(Rs) 54.33-44.2617.0052.4650.10

What is the latest Cash Earnings per Share (CEPS) ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Earnings per Share (CEPS) ratio of GLENMARK PHARMACEUTICALS is 54.33 based on Mar2025 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar202554.33
Mar2024-44.26
Mar202317.00
Mar202252.46
Mar202150.10

How is Cash Earnings per Share (CEPS) of GLENMARK PHARMACEUTICALS Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2025 54.33
Positive
Mar2024 -44.26
Negative
Mar2023 17
-67.59
Mar2022 52.46
4.71
Mar2021 50.1 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Cash Earnings per Share (CEPS) ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹65,610.1 Cr -1.1% 2.9% 69.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,075.0 Cr 0.4% 10.8% 10.5% Stock Analytics
DIVIS LABORATORIES ₹179,486.0 Cr 0.7% 9.5% 16.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,124.0 Cr -2.5% 6% 36.2% Stock Analytics
CIPLA ₹115,641.0 Cr 9.7% 16.7% -4.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,589.0 Cr 4.5% 9.7% 9% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.1%

2.9%

69.4%

SENSEX

-2.7%

-2.1%

-5.3%


You may also like the below Video Courses